ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Obesity
Foot Ulcer
Ulcer

Diabetes trials near Chicago, IL, USA:

E3 Diabetes - Closing the Gap in Diabetes Control (E3Diabetes)

This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Cen...

Invitation-only
Type 2 Diabetes
Behavioral: E3 Self-Guided Type 2 Diabetes Education
Behavioral: E3 Multidisciplinary Team
Rush
Rush

Chicago, Illinois, United States

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Evanston, Illinois, United States and 45 other locations

Locations recently updated

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Chicago, Illinois, United States and 17 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Chicago, Illinois, United States and 26 other locations

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Chicago, Illinois, United States and 56 other locations

placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...

Enrolling
Diabetes, Type II
Obesity
Drug: AZD6234
Drug: Placebo to match

Phase 2

AstraZeneca
AstraZeneca

Chicago, Illinois, United States and 17 other locations

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...

Enrolling
Type 1 Diabetes
Drug: DFMO
Drug: Placebo

Phase 2

Emily K. Sims

Chicago, Illinois, United States and 5 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Chicago, Illinois, United States and 40 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Chicago, Illinois, United States and 78 other locations

Phase 2 dose (RP2D) in adult subjects with unstable Type 1 Diabetes Mellitus (T1DM) and a level 3 (severe) hypoglycemic episode at least thr...

Enrolling
Diabetes Mellitus, Type 1
Hypoglycemia
Combination Product: OPF-310

Phase 1, Phase 2

Otsuka
Otsuka

Chicago, Illinois, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems